Lack of adverse cardiac effects of combined treatment with theophylline and albuterol in asthmatic children

V. Bastianon, A. Di Fazio, V. Colloridi, C. Marzano, A. Ferrucci, S. Pucci, L. Bernardini, F. Coletta, N. Sorbara, L. Businco

Research output: Contribution to journalArticlepeer-review

Abstract

Our study was designed to asses potential cardiovascular adverse effects in clinically stable asthmatic children due either to oral sustained-release theophylline or theophylline in combination with an inhaled beta-2 adrenergic agonist. Twenty-five asthmatic children were evaluated while receiving no drugs, theophylline alone, and theophylline with an inhaled beta-2 adrenergic agonist. In each phase all patients underwent 24- to 48-hour Holter monitoring and a maximal treadmill exercise test. The results show that neither theophylline alone nor combined therapy was associated with any relevant cardiovascular adverse effect, including ectopic cardiac activity. A nonsignificant increase in mean heart rate was observed between each period of study. The data suggest that the use of theophylline either alone or in combination with a beta-2 adrenergic agonist in clinically stable asthmatic children is not associated with any serious cardiovascular effect.

Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalAnnals of Allergy
Volume65
Issue number3
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Lack of adverse cardiac effects of combined treatment with theophylline and albuterol in asthmatic children'. Together they form a unique fingerprint.

Cite this